Members of a homologous series of pyrrolo[2,1-
c][1,4]benzodiazepine (PBD) dimers withC8-O-(CH
2)
n-O-C8' diether linkages (
n = 3-6 for
2a-d, respectively) have been studied for their abilityto interact with oligonucleotide duplexes containing potential target binding sites. The results confirmearlier predictions that the
n = 3 analogue (
2a, DSB-120) will covalently bind to a 5'-Pu-
GATC-Py sequenceby cross-linking opposite-strand guanines separated by 2 bp. Preference for this DNA sequence is shownusing oligonucleotides with altered bases between and/or flanking these guanines. The more extendedPBD dimer
2c (
n = 5) can span an extra base pair and cross-link the 5'-Pu-
GA(T/
A)TC-Py sequence. Theability of each homologue to cross-link linear plasmid DNA has been determined, with a rank order thatcorrelates with the reported order of
in vitro cytotoxicity:
n = 3 (
2a) >
n = 5 (
2c) >
n = 6 (
2d) >
n= 4 (
2b). The
n = 3 homologue (
2a) is >300-fold more efficient at cross-linking DNA than the clinicallyused cross-linking agent melphalan under the same conditions. Kinetic studies reveal that the
n = 3 and5 dimers achieve faster cross-linking to plasmid DNA (108 and 81% cross-linking h
-1 ![](/images/entities/mgr.gif)
M
-1 at 37
![](/images/entities/deg.gif)
C,respectively), whereas the
n = 4 and 6 homologues are significantly less efficient at 10.3 and 23% cross-linking h
-1 ![](/images/entities/mgr.gif)
M
-1, respectively. Alternating activity for the odd
n and even
n dimers is probably due toconfigurational factors governed by the spatial separation of the PBD subunits and the flexible characterof the tethering linkage. Molecular modeling confirms the order of cross-linking reactivity, and highlightsthe role of linker length in dictating sequence recognition for this class of DNA-reactive agent.